P
ELV icon

&Partners’s Elevance Health ELV Stock Holding History

&Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Sell
12,140
-96
-0.8% -$31.6K 0.02% 652
2025
Q4 		$4.29M Buy
12,236
+2,166
+22% +$732K 0.02% 553
2025
Q3 		$3.26M Sell
10,070
-154
-2% -$47.9K 0.02% 559
2025
Q2 		$4M Buy
10,224
+2,165
+27% +$871K 0.03% 428
2025
Q1 		$3.48M Buy
8,059
+1,906
+31% +$765K 0.04% 382
2024
Q4 		$2.28M Sell
6,153
-115
-2% -$48.1K 0.03% 458
2024
Q3 		$3.26M Buy
6,268
+2,488
+66% +$1.33M 0.06% 272
2024
Q2 		$2.05M Buy
3,780
+2,591
+218% +$1.37M 0.09% 211
2024
Q1 		$617K Buy
1,189
+661
+125% +$329K 0.09% 230
2023
Q4 		$249K Sell
528
-48
-8% -$22.2K 0.06% 240
2023
Q3 		$251K Hold
576
– – 0.12% 141
2023
Q2 		$256K Buy
576
+57
+11% +$26.3K 0.11% 145
2023
Q1 		$238K Buy
519
+1
+0.2% +$476 0.11% 143
2022
Q4 		$266K Buy
518
+469
+957% +$238K 0.13% 137
2022
Q3 		$254K Buy
+49
New +$23.4K 0.15% 136

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

&Partners's ELV Position: Q1 2026 in Review

&Partners reduced its Elevance Health (ELV) stake by 0.78% in Q1 2026, selling an estimated $31.6K and leaving 12,140 shares worth $3.55M. The position accounts for 0.02% of the portfolio, ranked #652.

&Partners first reported a position in ELV in Q3 2022 and has held it in 15 quarters since. The position peaked at $4.29M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • &Partners held 12,140 shares of Elevance Health worth $3.55M as of Q1 2026.
  • &Partners sold 96 Elevance Health shares in Q1 2026, an estimated $31.6K.
  • Elevance Health made up 0.02% of &Partners's portfolio in Q1 2026, its #652 holding.
  • &Partners first reported a position in Elevance Health in Q3 2022 and has held it in 15 quarters since.
  • &Partners's Elevance Health position peaked at $4.29M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.